Table VII.
Model | Intercept | BMI | log(PSA) | Age | DRE | Year |
---|---|---|---|---|---|---|
Model 7 | -6.692, -2.004 | -0.023, 0.073 | 0.112, 1.022 | 0.020, 0.070 | -0.156, 0.654 | -0.418, -0.157 |
Model 8 | -5.370, -1.781 | Omitted | 0.115, 1.025 | 0.019, 0.069 | -0.148, 0.661 | -0.418, -0.157 |
Model 9 | -6.413, -1.759 | -0.022, 0.074 | Omitted | 0.024, 0.074 | -0.018, 0.763 | -0.428, -0.168 |
Model 10 | -2.391, 0.445 | -0.032, 0.063 | 0.221, 1.127 | Omitted | -0.127, 0.672 | -0.426, -0.168 |
Model 11 | -6.778, -2.102 | -0.022, 0.074 | 0.195, 1.079 | 0.021, 0.071 | Omitted | -0.384, -0.139 |
Model 12 | -7.440, -2.870 | -0.024, 0.071 | 0.188, 1.094 | 0.023, 0.072 | -0.413, 0.340 | Omitted |
DRE, digital rectal examination; HGPCa, high-grade prostate cancer; PCa, prostate cancer; PSA, prostate specific antigen.